
BLK-Max Super Speciality Hospital
One of India's largest super-speciality private hospitals and a flagship of the Max Healthcare network, with a comprehensive Cancer Centre, one of Asia's largest Bone Marrow Transplant programmes, advanced robotic surgery, high-volume liver and kidney transplant services, and a dedicated international patient programme serving patients from South Asia, Africa, the Middle East and the CIS countries.
About BLK-Max Super Speciality Hospital
BLK-Max Super Speciality Hospital is one of India's largest private tertiary hospitals, located on Pusa Road in the Rajendra Place area of central New Delhi. The hospital was founded by Dr. B.L. Kapur, a renowned obstetrician and gynecologist who had earlier set up a charitable hospital in Lahore in 1930 and a maternity hospital in Ludhiana in 1947. On the invitation of India's first Prime Minister Pt. Jawaharlal Nehru, Dr. Kapur initiated a 200-bed hospital project in Delhi, which was formally inaugurated by Nehru on 2 January 1959. The hospital was later redeveloped and re-launched as a multi super-speciality facility with 650-bed capacity and is now part of the Max Healthcare network, India's largest private hospital chain. Spread across approximately 650,000 sq ft (~60,400 m²), BLK-Max today has 650 inpatient beds, 162 critical care beds, 22 modular operation theatres, and more than 1,500 healthcare professionals including 150 globally renowned super-specialists and 300 senior consultants.
BLK-Max's Cancer Centre delivers integrated medical, surgical and radiation oncology under one roof, covering head and neck, thoracic, breast, gastrointestinal, hepatobiliary, gynecologic, urologic and pediatric oncology, alongside hematologic malignancies. Cancer treatment infrastructure includes TomoTherapy (image-guided IMRT), HDR brachytherapy, total body irradiation, robotic surgical platforms, PET-CT, high-end MRI and CT imaging, and India's first dedicated Endoscopy Suite for Endoscopic Ultrasound. The Bone Marrow Transplant Centre, led by Dr. Dharma Choudhary, is recognised as one of Asia's largest BMT centres and was the first in Delhi to perform an unrelated donor stem cell transplant for thalassemia major. The Liver Transplant Centre has reportedly performed the maximum number of deceased-donor organ retrievals and transplants in Northern India, and BLK-Max was India's first private facility to install a dual-console robotic surgical system.
BLK-Max is accredited by Joint Commission International (JCI), the National Accreditation Board for Hospitals and Healthcare Providers (NABH) and the National Accreditation Board for Testing and Calibration Laboratories (NABL), reflecting compliance with both Indian and international healthcare standards. The hospital has won the 'Best Multi-Specialty Hospital - Metro' award at the CNBC-TV18 Healthcare and Wellness Awards 2017, the Trusted Hospital Award at the India Today Health Summit 2018, and the AHPI Award for Quality Beyond Accreditation in both 2017 and 2018. As part of the wider Max Healthcare group, BLK-Max benefits from the network's broader clinical expertise spanning thousands of doctors and multiple hospitals across India. The hospital is the first in the Delhi NCR region to operate an automatic pneumatic chute system and houses India's first computer-navigated joint replacement programme.
CancerFax works directly with BLK-Max's International Patient Services team to help patients from outside India, particularly from South Asia, Central Asia, Africa, the Middle East, Russia, the CIS countries and South-East Asia, access the hospital's oncology, BMT and organ transplant programmes. From sharing your medical records for preliminary clinical review, to arranging the right department or multidisciplinary consultation, securing Indian Medical Visa support, coordinating accredited translation of reports, complimentary airport transfers, hotel bookings and pre-arrival cost estimates, CancerFax manages the entire pathway at no cost to the patient. We also serve Indian patients seeking a coordinated second opinion at BLK-Max alongside other leading Indian cancer hospitals, so the choice of where to receive treatment is grounded in clinical fit, not in logistics or guesswork.
| Hospital at a Glance | |
|---|---|
| Country | India |
| City | New Delhi (Pusa Road, Rajendra Place) |
| Established | 1959 (inaugurated by PM Jawaharlal Nehru on 2 January 1959); now part of Max Healthcare |
| Hospital Type | Private Tertiary Super-Speciality Hospital · Flagship of the Max Healthcare network |
| Accreditation | JCI · NABH · NABL Accredited |
| Beds | 650 inpatient beds (incl. 162 critical care beds) |
| Operation Theatres | 22 modular operation theatres |
| Clinical Focus | Oncology, bone marrow transplant, liver and kidney transplantation, robotic surgery, cardiac sciences, neurosciences |
Why Patients Choose BLK-Max Super Speciality Hospital
BLK-Max combines six decades of clinical heritage with the scale and standards of the Max Healthcare network, offering comprehensive multi-modality cancer care, one of Asia's largest BMT programmes, advanced robotic surgery and a structured international patient pathway.
Cancer Specialties and Clinical Departments
BLK-Max delivers tumour-specific care through dedicated oncology departments and the Cancer Centre, supported by Asia-scale BMT and transplant infrastructure and the broader Max Healthcare network of multi-disciplinary teams.
Advanced Treatment Capabilities
Key Specialists at BLK-Max Super Speciality Hospital
BLK-Max has more than 1,500 healthcare professionals, including 150 globally renowned super-specialists and 300 senior medical experts working across the Cancer Centre, BMT Centre, Liver Transplant Centre, Kidney Transplant Centre, Cardiac Sciences, Neurosciences, Orthopedics and other super-speciality departments. Senior oncology and transplant leadership includes Dr. Dharma Choudhary (Bone Marrow Transplant), Dr. Sandeep Mehta (Surgical Oncology), Dr. Chandragouda Dodagoudar (Medical and Pediatric Oncology), Dr. Pramoj Jindal (Thoracic Oncology Surgery and Lung Transplant), Dr. Prashant Jain (Pediatric and Robotic Surgery), Dr. Anil Kumar Kansal (Neurosciences and Spine Surgery), Dr. Abhideep Chaudhary and Dr. Yajvender Pratap Singh Rana (Liver Transplant), and Dr. Ajay Kaul (Cardiac Surgery).
BLK-Max follows a multidisciplinary tumour board model for complex oncology cases, bringing medical, surgical and radiation oncologists together with pathology, radiology, nuclear medicine, palliative care and supportive care teams to align on individualised treatment plans. Patients seeking consultation with a specific physician or a second opinion may submit their request through the CancerFax coordination process. We work with BLK-Max's International Patient Services team to match each case to the appropriate clinical lead and arrange video or in-person consultations before any travel is confirmed.
Patients seeking specific physician consultations or second opinions may request a review through the CancerFax coordination process before confirming travel or admission.
Clinical Infrastructure and Treatment Technology
BLK-Max's Pusa Road campus integrates one of Delhi's most extensive private hospital infrastructures with advanced cancer treatment technology, India's first private dual-console robotic system, 22 modular operation theatres and one of Asia's largest BMT units.
- TomoTherapy — next-generation image-guided intensity-modulated radiation therapy (IGRT/IMRT)
- HDR brachytherapy for cervical, prostate, breast and head and neck cancers
- Total Body Irradiation (TBI) suite supporting bone marrow transplant conditioning regimens
- PET-CT, high-end MRI and CT scanners for oncology staging and treatment response
- India's first dedicated Endoscopy Suite for Endoscopic Ultrasound (EUS)
- Bronchoscopy suites and advanced pathology and molecular diagnostics laboratories
- 22 modular operation theatres with advanced air filtration and gas scavenging systems
- India's first private dual-console robotic surgical system supporting urology, gynecology, GI, joint replacement and spine surgery
- India's first computer-navigated joint replacement platform and advanced minimally invasive spine surgery
- One of Asia's largest Bone Marrow Transplant centres performing allogeneic, haploidentical, matched-unrelated donor (MUD), autologous and cord blood transplants
- First centre in Delhi to perform an unrelated donor stem cell transplant for thalassemia major
- Dedicated HEPA-filtered transplant rooms with stringent infection control supported by 162 critical care beds across the hospital
International Patient Support at BLK-Max Super Speciality Hospital
BLK-Max operates a structured International Patient Services team supporting patients from South Asia, Central Asia, Africa, the Middle East, Russia, the CIS countries and South-East Asia, covering pre-arrival assessment, visa documentation, interpreter services, accommodation and in-hospital coordination.
What to Prepare Before Traveling
- arrow_rightShare complete pathology reports, biopsy slides, recent imaging (CT, PET-CT, MRI), molecular profiling, prior treatment summaries and any HLA typing in English with BLK-Max's International Patient Services team at least one to two weeks before your planned consultation date.
- arrow_rightApply for an Indian Medical Visa (MED category) at the Indian embassy or consulate in your country, plus a Medical Attendant Visa (MED X) for up to two accompanying family members. CancerFax can arrange the official hospital invitation letter required for the visa application.
- arrow_rightPlan your travel via Indira Gandhi International Airport (DEL), approximately 19 km from the hospital. BLK-Max offers complimentary airport pickup and drop for international IPD patients, and the Pusa Road campus is a short walk from Rajendra Place Metro Station (Blue Line).
To reach BLK-Max's International Patient Services directly, phone or WhatsApp +91 92688 80303 or visit blkmaxhospital.com. CancerFax coordinates all communication with the hospital on your behalf, including translation of foreign-language reports, visa documentation, video consultations and in-Delhi logistics, and remains your single point of contact through admission, treatment and post-treatment follow-up at no cost.
Patient Facilities and Accommodation at BLK-Max Super Speciality Hospital
BLK-Max's Pusa Road campus combines hospital-grade clinical care with multi-tier patient accommodation, ranging from general wards through to deluxe private suites, alongside on-campus dining, a 24/7 pharmacy and dedicated international patient support.
Family members travelling with international patients can choose from a wide range of accommodation around the hospital, from budget guest houses such as Hotel Livasa Inn and Le Heritage through to five-star options including Jaypee Siddharth. BLK-Max's International Patient Services team and CancerFax can both assist with bookings, daily transport and longer-stay arrangements for post-treatment follow-up periods.
How to Reach BLK-Max Super Speciality Hospital
BLK-Max's main campus sits on Pusa Road in central New Delhi's Rajendra Place area, well connected by Delhi Metro and within a 30 to 40-minute drive of Indira Gandhi International Airport (DEL), India's busiest international airport.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
BLK-Max Super Speciality Hospital — Patient Questions Answered
CancerFax acts as your dedicated coordinator for the entire BLK-Max journey. You begin by sharing your medical records, including pathology, biopsy slides, scans and prior treatment summaries, through our secure intake. Our clinical team reviews your case and identifies which BLK-Max department or sub-specialty is the right fit, whether that is the Cancer Centre, the Bone Marrow Transplant Centre, the Liver or Kidney Transplant Centres, robotic surgery, or a complex multidisciplinary tumour board review. We then submit your case to BLK-Max's International Patient Services team and work with their clinical liaison to secure the right consultation or video review.
Once your appointment is confirmed, CancerFax assembles your full pre-travel pack: itemised cost estimates from BLK-Max with no CancerFax mark-up, Indian Medical Visa invitation letters, translation of your home-country reports where needed, airport pickup confirmation, accommodation recommendations near the Rajendra Place campus, and guidance on what to bring. We remain your single point of contact through admission, treatment and follow-up. There is no fee to the patient for any of this coordination, whether you are travelling from outside India or seeking a coordinated second opinion as an Indian resident.
BLK-Max is best known for its comprehensive multi-modality Cancer Centre and one of Asia's largest Bone Marrow Transplant programmes. The Cancer Centre integrates medical, surgical and radiation oncology under one roof, with strong programmes in head and neck cancer, thoracic and lung cancer, breast cancer, gastrointestinal and hepatobiliary cancer, gynecologic, urologic and pediatric oncology, plus hematologic malignancies (leukemia, lymphoma, myeloma) supported by the BMT Centre. Radiation infrastructure includes TomoTherapy, HDR brachytherapy and total body irradiation, and the hospital is recognised for robotic cancer surgery across multiple specialties. The Liver and Kidney Transplant programmes also handle oncologic transplant indications such as hepatocellular carcinoma. If you are unsure whether BLK-Max is the right fit for your specific diagnosis, share your records through CancerFax and we will confirm departmental fit before any travel commitment.
BLK-Max's Bone Marrow Transplant Centre is one of Asia's largest and offers the full range of allogeneic, haploidentical, matched-unrelated donor (MUD), autologous and cord blood transplants for adult and pediatric patients, including thalassemia and sickle cell indications. The hospital is India's first private facility to install a dual-console robotic surgical system and runs an active robotic surgery programme across urology, gynecology, GI, joint replacement and spine.
⚠ VERIFY: BLK-Max's main service pages do not specifically advertise CAR-T, CAR-NK or TIL cell therapy as routine clinical services as of writing. For cellular immunotherapy options, CancerFax can confirm current availability at BLK-Max via the International Patient Services team and also help you compare options across other Indian and international cellular immunotherapy centres, so your treatment choice is based on what is currently possible for your case rather than on outdated information.
Yes. BLK-Max offers video consultations and remote second opinion services for international and Indian patients through its International Patient Services team. The process involves submitting your scans, pathology reports, biopsy slides where requested, and prior treatment summaries, ideally in English, for review by the relevant tumour-specific or transplant team. CancerFax facilitates this submission, follows up on your behalf, and obtains a written preliminary opinion or treatment direction, typically within one to two weeks depending on case complexity. This is particularly valuable for international patients considering long travel for BMT, liver transplant or major oncology surgery, since a video consultation can often confirm eligibility and indicative cost ranges before any flight is booked.
Treatment costs at BLK-Max are typically a fraction of those at comparable hospitals in the United States, Western Europe or the Middle East, while clinical quality is anchored by JCI, NABH and NABL accreditation and the broader Max Healthcare network. Exact pricing depends heavily on the diagnosis, room category (general ward, semi-private, private or deluxe), the specific procedure (chemotherapy, radiation, surgery, BMT or transplant) and the length of stay. BLK-Max's International Patient Services team provides itemised written cost estimates as part of the pre-arrival pathway, and CancerFax shares these with you at no extra charge and with no mark-up on hospital fees. The hospital is empanelled with most major Indian insurance companies and many international TPAs for cashless hospitalisation; CancerFax can advise on the supporting documentation BLK-Max issues for reimbursement claims with your specific insurer.
Send Your Medical Reports to BLK-Max Super Speciality Hospital via CancerFax
CancerFax reviews your records, identifies the right BLK-Max department, and coordinates your consultation, BMT or surgical opinion in New Delhi, at no cost, with no obligation, and with full medical confidentiality throughout.